Search by Drug Name or NDC

    NDC 72888-0200-12 mycophenolic acid 360 mg/1 Details

    mycophenolic acid 360 mg/1

    mycophenolic acid is a ORAL TABLET, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Advagen Pharma Limited. The primary component is MYCOPHENOLATE SODIUM.

    Product Information

    NDC 72888-0200
    Product ID 72888-200_8eaa9257-7fe9-4b5c-8de6-3c8f68901627
    Associated GPIs
    GCN Sequence Number 052120
    GCN Sequence Number Description mycophenolate sodium TABLET DR 360 MG ORAL
    HIC3 Z2E
    HIC3 Description IMMUNOSUPPRESSIVES
    GCN 19647
    HICL Sequence Number 025201
    HICL Sequence Number Description MYCOPHENOLATE SODIUM
    Brand/Generic Generic
    Proprietary Name mycophenolic acid
    Proprietary Name Suffix n/a
    Non-Proprietary Name mycophenolic acid
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 360
    Active Ingredient Units mg/1
    Substance Name MYCOPHENOLATE SODIUM
    Labeler Name Advagen Pharma Limited
    Pharmaceutical Class Antimetabolite Immunosuppressant [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA211173
    Listing Certified Through 2024-12-31

    Package

    NDC 72888-0200-12 (72888020012)

    NDC Package Code 72888-200-12
    Billing NDC 72888020012
    Package 120 TABLET, DELAYED RELEASE in 1 BOTTLE (72888-200-12)
    Marketing Start Date 2023-11-10
    NDC Exclude Flag N
    Pricing Information N/A